This inventor holds 17 USPTO granted patents and 7 published patent applications and 6 EPO patents, primarily in Targeted Protein Degradation. Top assignees: Osi Pharmaceuticals, Inc., Arvinas Operations, Inc., Yale University. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Farmingdale, NY (US) (2010)
- Commack, NY (US) (2011 - 2015)
- Trumbull, CT (US) (2014 - 2022)
Company Filing History:


Years Active: 2010-2025
Areas of Expertise:
Title: **Innovator Spotlight: Xin Chen**
Introduction
Xin Chen is an accomplished inventor based in Commack, NY, United States. With a remarkable portfolio of 17 patents, he has made significant contributions to the field of biotechnology, particularly in the development of compounds that target the degradation of specific proteins. His pioneering work showcases a strong understanding of pharmacological activities associated with targeted protein modulation.
Latest Patents
Among his latest innovations, Xin Chen has patented two noteworthy discoveries. The first is focused on **Compounds and methods for the targeted degradation of androgen receptor**. This invention introduces bifunctional compounds that facilitate the degradation and inhibition of the Androgen Receptor, utilizing a VHL ligand to bind to the ubiquitin ligase, alongside a moiety that targets the androgen receptor. This innovative approach demonstrates a spectrum of pharmacological activities related to effective degradation.
The second patent involves **Compounds and methods for the enhanced degradation of targeted proteins**. Similar to his first innovation, this invention employs bifunctional compounds to modulate targeted ubiquitination, specifically as inhibitors for various polypeptides and proteins. The methodology positions the target protein close to the ubiquitin ligase, promoting its degradation. Both inventions underline Xin's expertise in developing compounds that bring transformative changes in biomedical applications.
Career Highlights
Xin Chen’s professional journey includes notable tenures at Osi Pharmaceuticals, Inc. and Arvinas Operations, Inc., where he applied his innovative expertise to advance drug discovery and development. His work in these organizations highlights his commitment to improving therapeutic strategies through cutting-edge research.
Collaborations
Throughout his career, Xin has worked with talented individuals, including Andrew Philip Crew and Jing Wang. Collaboration with such colleagues has fostered an environment of ingenuity, allowing Xin to further enhance his inventions and drive forward the frontiers of science.
Conclusion
Xin Chen stands out as a vital contributor to the field of biotechnology, with his extensive patent portfolio attesting to his inventive spirit. His latest patents, aimed at targeted protein degradation, signify a remarkable advancement in therapeutic methodologies. As an inventor, Xin continues to influence the scientific landscape, demonstrating the crucial role of innovation in addressing complex biomedical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile